|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | |
| A61K 38/16 | |||
| A61P 3/10 |
| (11) | Number of the document | 2922876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13856357.2 |
| Date of filing the European patent application | 2013-11-20 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071077 |
| Date | 2013-11-20 |
| (87) | Number | WO 2014/081872 |
| Date | 2014-05-30 |
| (30) | Number | Date | Country code |
| 201261728649 P | 2012-11-20 | US |
| (72) |
NESTOR, John, J., US
|
| (73) |
Mederis Diabetes, LLC,
7515 Guinevere Drive, Sugar Land, Texas 77479,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |
| IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |